FRAMINGHAM, Mass.--(BUSINESS WIRE)--Clinical Enterprise, Inc. d/b/a empowerDX, who offers the at-home Celiac Risk Gene Test, announced today that they have entered into an exclusive partnership with NIMA Partners, the makers of Gluten Sensor and Gluten Capsules for the detection of gluten in food particles.
This partnership is characteristic of the ethos defining the mission of empowerDX – creating awareness and education for the many individuals with misdiagnosed or underdiagnosed diseases. Our goal to provide access to testing upon the foundation of awareness and education has resulted in solutions that bridge the gap between demand and access to testing.
“This partnership is part of NIMA Partners’ continued commitment to increase the level of service we offer those who suffer from Celiac Disease and Gluten Intolerance,” said NIMA Partners CEO, David DellaFave. “Raising awareness about this incredible new product from empowerDX aligns with our greater mission to educate, advocate, and raise awareness for those who suffer from these devastating disease states.”
Celiac disease is a genetic autoimmune condition where the body’s immune system attacks the small intestine when gluten is consumed. More than 99% of people who develop celiac disease carry one of the genetic variants identified by empowerDX’s Celiac Risk Gene Test. Because this is a hereditary disease, family members should be aware of their risk. 10% of individuals with celiac disease have an affected first-degree relative (parent, sibling, child). Collaborating with NIMA Partners, empowerDX is helping to educate families about genetic testing for celiac disease.
For more information on the empowerDX, please visit empowerDXlab.com.
ABOUT EMPOWERDX:
Launched in 2019 empowerDX is the online shop for easy at-home health testing. empowerDX specializes in FDA-authorized COVID-19 testing, women’s health, men’s health, sexual health, and general wellness testing. Along with its affiliated CLIA-certified clinical laboratories in the U.S., empowerDX is positioned to lead the market for cutting edge, self-collected diagnostic and non-diagnostic testing. All clinical tests are reviewed by empowerDX’s licensed ordering physician to eliminate the need for a phlebotomist or a telemedicine-observed sample collection. Welcome to health clarity with just a few clicks. The company is based outside of Boston, in Framingham, MA and is a subsidiary of the Eurofins Group. To learn more, please visit empowerdxlab.com.
ABOUT NIMA Partners:
Launched in 2021, NIMA Partners offers a Gluten Sensor and Gluten Capsules for the detection of Gluten in food particles for those that suffer from Celiac Disease and Gluten Intolerance. They have a strong focus on educating the community through an Ecosystem approach. Individuals who suffer from these disease states all live in their own Ecosystem and as a result need to follow a number of different tenets to ensure that they can live their best life….the NIMA Partners product being a part of this Ecosystem. For more information about NIMA Partners please visit www.nimapartners.com and also @nimapartners on Facebook, Instagram, Twitter, and LinkedIn.
ABOUT EUROFINS – the global leader in bio-analysis
Eurofins is Testing for Life. With 58,000 staff across a network of 900 laboratories in 54 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.
Eurofins Shares are listed on Euronext Paris Stock Exchange.
